Ondine Biomedical, Inc.(GB:OBI)
GBXÂ 9.10+0.20 (+2.25%)
GB:OBI
Ondine Biomedical, Inc. financials statements
GBXÂ 9.10
At close:+0.20 (+2.25%)
Want to see GB:OBI full AI Analyst Report?
Ondine Biomedical, Inc. (OBI) Income Statement
17 Followers
Ondine Biomedical, Inc. Income Statement
Last quarter (Q2 2026), Ondine Biomedical, Inc.'s total revenue was C$1.23M, an increase of 42.16% from the same quarter last year. In Q2, Ondine Biomedical, Inc.'s net income was C$-15.96M. See Ondine Biomedical, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| C$ 2.65M | C$ 2.05M | C$ 1.20M | C$ 638.00K | C$ 2.57M | |
| C$ 1.09M | C$ 1.32M | C$ 703.00K | C$ 287.00K | C$ 1.25M | |
| C$ 31.13M | C$ 20.77M | C$ 15.51M | C$ 19.05M | C$ 18.77M | |
| Depreciation and Amortization | C$ 591.43K | C$ 565.00K | C$ 587.00K | C$ 493.00K | C$ 514.00K |
| C$ -29.45M | C$ -18.49M | C$ -13.79M | C$ -18.85M | C$ -48.36M | |
| C$ -30.04M | C$ -19.44M | C$ -14.80M | C$ -18.76M | C$ -17.52M | |
| C$ 451.09K | C$ 346.00K | C$ 393.00K | C$ -609.00K | C$ -32.56M | |
| C$ -29.59M | C$ -19.10M | C$ -14.41M | C$ -19.37M | C$ -50.09M | |
| C$ -29.59M | C$ -19.10M | C$ -14.41M | C$ -19.37M | C$ -50.09M | |
| Per Share Metrics | |||||
| Basic EPS | C$ -0.06 | C$ -0.07 | C$ -0.07 | C$ -0.10 | C$ -0.26 |
| Diluted EPS | C$ -0.06 | C$ -0.07 | C$ -0.07 | C$ -0.10 | C$ -0.26 |
| Weighted Average Shares Outstanding | 465.08M | 274.60M | 197.11M | 194.59M | 194.59M |
| Weighted Average Shares Outstanding (Diluted) | 465.08M | 274.60M | 197.11M | 194.59M | 194.59M |
Currency in CAD
